Events

Wellbeing at Work Summit w/ Rohan Kallicharan

Panel Discussion: Successful International Wellbeing Strategies

5th November | 9:50 - 10.25

Join BenevolentAI’s HR Director and Mind campaigner, Rohan for a panel discussion on the secrets to achieving international wellbeing strategy success.

Register →


Rohan Kallicharan
HR Director

Rohan is HR Director at BenevolentAI and an ambassador for Mind, the mental health charity. He has advised a number of high profile companies on their mental wellbeing strategy, as well as involvement in national campaigns to raise awareness around mental health.Recently, he has worked with the FA, Heads Together and Kensington Palace, speaking to Sky News, the BBC and ITV about his own journey from severe mental illness and homelessness to advocacy, and championing the significant role of sport and football in breaking down barriers in talking about mental wellbeing, especially for young men.

More Posts

You Might Also Like

Blog
Transforming drug discovery with AI: how we’re building and nurturing the best talent for the job
At BenevolentAI, we are on a mission to bring life-changing medicines to patients, and we are looking for collaborative, mission-driven people to join our tech, drug discovery and business operations teams in London, Cambridge and New York.
Oct 17, 2021
News
BenevolentAI identifies novel target for ulcerative colitis and advances candidate to IND/CTA-enabling studies
BenevolentAI’s AI-Drug Discovery platform uncovered a novel target not previously linked to ulcerative colitis and advanced candidate to preclinical studies.
Oct 14, 2021
Blog
Measuring bias: moving towards more inclusive health research outcomes #stateofai
Having shared our open-source Diversity Analysis Tool last year, we were tasked to investigate and demonstrate the lack of diversity in biomedical data as part of the State of AI Report 2021.
Oct 12, 2021
Blog
Expert-augmented computational drug discovery for rare diseases
Combining scientific expertise, computational tools and our AI-enhanced biomedical knowledge graph to successfully uncover a new drug combination for treating a rare brain cancer in children.
Sep 28, 2021
News
BenevolentAI appoints Dr John Orloff to its Board of Directors
Biopharmaceutical veteran Dr John Orloff joins the BenevolentAI Board as a Non-Executive Director as it scales the development of its leading AI-derived drug pipeline.
Sep 9, 2021
Blog
AI in Drug Discovery
This blog seeks to demystify the application of artificial intelligence (AI) and machine learning (ML) in drug discovery by exploring some of the challenges, opportunities and progress that has been achieved in the field so far.
Jul 13, 2021